Abdelhaleem EF, Abdelhameid MK, Kassab AE, Kandeel MM (2018) Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7. Eur J Med Chem 143: 1807-1825. https://doi.org/10.1016/j.ejmech.2017.10.075
Ahmed MS, Elsenduny FF, Taylor J, Halaweish FT (2017) Biological screening of cucurbitacin inspired estrone analogs targeting mitogen‐activated protein kinase (MAPK) pathway. Chem Biol Drug Des 90: 478-484. https://doi.org/110.1111/cbdd.12963
Albert B, Gibalova L, Seres M, Barancik M, Sulova Z (2013) New insight into p-glycoprotein as a drug target. Anti-cancer Agents Med Chem 13: 159–170. https://doi.org/10.2174/1871520611307010159
Azarova AM, Lyu YL, Lin C-P, Tsai Y-C, Lau JY-N, Wang JC, Liu LF (2007) Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proceedings of the National Academy of Sciences 104: 11014–11019. https://doi.org/10.1073/pnas.0704002104
Chen G (2015) Clinical Observation and Experimental Study on the Treatment of Breast Cancer with the Method of Warming Yang and Dissipating Phlegm Beijing University of Chinese Medicine
da Silva AWS, Vranken WF (2012) ACPYPE-Antechamber python parser interface. BMC research notes 5: 367. https://doi.org/10.1186/1756-0500-5-367
Du Y, Zhou Q, Yin W, Zhou L, Di G, Shen Z, Shao Z, Lu J (2011) The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures. Breast cancer research and treatment 129: 839. https://doi.org/10.1007/s10549-011-1694-9
Duan F, Lang L, Zhang X, Hao X, Zhang Y, Zhao S (2018) Effect and Complications for Sini Decoction Combined with Western Medicine Treatment on Advanced Breast Cancer after Operation. Chinese Archives of Traditional Chinese Medicine 36: 1774-1776.
Felix CA (1998) Secondary leukemias induced by topoisomerase-targeted drugs. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1400: 233-255. https://doi.org/10.1016/S0167-4781(98)00139-0
Ganapath RN, Ganapathi MK (2013) Mechanisms regulating resistance to inhibitors of topoisomerase II. Frontiers in pharmacology 4: 89. https://doi.org/10.3389/fphar.2013.00089
Götz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC (2012) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized Born. Journal of chemical theory and computation 8: 1542-1555. https://doi.org/10.1021/ct200909j
Guo B, Tam A, Santi SA, Parissenti AM (2016) Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells. BMC cancer 16: 762. https://doi.org/10.1186/s12885-016-2790-3
Hanuman JB, Katz A (1994) New Lipo Norditerpenoid Alkaloids from Root Tubers of Aconitum ferox. Journal of Natural Products 57: 105-115. https://doi.org/10.1021/np50103a015
Hazawa M, Takahashi K, Wada K, Mori T, Kawahara N, Kashiwakura I (2009a) Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin’s lymphoma Raji cells and human hematopoietic stem/progenitor cells. Investigational new drugs 29: 1-8. https://doi.org/10.1007/s10637-009-9327-4
Hazawa M, Wada K, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2009b) Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs 27: 111-119. https://doi.org/10.1007/s10637-008-9141-4
He Shu, Xuecai Liu, Jia E (2009) Study on the anti-tumor effects of aconitides World Health Digest Medical Periodieal 6: 258.
Isao K, Zhaolong C, Minoru Y, Katsuya K, Masayuki Y, Naohiko O, Yuji Y (1984) Chemical Studies on Crude Drug Processing. III. Aconiti Tuber (2). : On the Constituents of \"Pao-fuzi\", the Processed Tuber of Aconitum carmichaeli DEBX. and Biological Activities of Lipo-alkaloids. Yakugaku Zasshi 104: 858-866. https://doi.org/10.1248/yakushi1947.104.8_858
Jun K-Y, Park S-E, Liang JL, Jahng Y, Kwon Y (2015) Benzo [b] tryptanthrin inhibits MDR1, topoisomerase activity, and reverses adriamycin resistance in breast cancer cells. Chem Med Chem 10: 827-835. https://doi.org/10.1002/cmdc.201500068
Khadka DB, Cho W-J (2013) Topoisomerase inhibitors as anticancer agents: a patent update. Expert Opin Ther Pat 23: 1033-1056. https://doi.org/10.1517/13543776.2013.790958
Kim S, Lee SR, Ooda H, Lee JI (2002) Pharmacologic evalution of some anti-cancer plants from Paikdooshan and their application. 한국자원식물학회지 15: 37-42.
Kitagawa I, Yoshikawa M, Chen ZL, Kobayashi K (1982) Four new lipo-alkaloids from Aconiti tuber. Chem Pharm Bull 30: 758-761.
Koji Wada MG, Takahiro Shimizu, Nami Kusanagi, Megumi Mizukami, Yuji Suzuki, Kang‑Po Li, Kuo‑Hsiung Lee, Hiroshi Yamashita (2019) Structure–activity relationships and evaluation of esterified diterpenoid alkaloid derivatives as antiproliferative agents. Journal of Natural Medicines 73: 789–799. https://doi.org/10.1007/s11418-019-01331-6
Latorre E, Tebaldi T, Gabriella Viero, Spartà AM, Quattrone A, Provenzani A (2012) Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Molecular cancer 11: 13. https://doi.org/10.1186/1476-4598-11-13
Li H, Liu XQ, Chen XY (2005) Using gene chip technology to investigate the mechanism of aconitine's reversing the drug resistance of the KBV_(200) Cell. Chinese Journal of Information on Tcm
Li T-K, Liu LF (2001) Tumor cell death induced by topoisomerase-targeting drugs. Annual Review of Pharmacology and Toxicology 41: 53-77. https://doi.org/10.1146/annurev.pharmtox.41.1.53
Liang X, Chen L, Song L, Fei W, He M, He C, Yin Z (2017) Diterpenoid alkaloids from the root of Aconitum sinchiangense W. T. Wang with their antitumor and antibacterial activities. Nat Prod Res 31: 2016-2023. https://doi.org/10.1080/14786419.2016.1272113
Liang X, Chen N, Gao Y, He C, Yin Z, Zou Y, Yin L, Song X (2016a) Preparation and application of 8-lipo-diterpenoid alkaloids. Chinese Patent: 201610776382.
Liang X, Gao Y, Luan S (2018) Two decades of advances in diterpenoid alkaloids with cytotoxicity activities. RSC Advances 8: 23937-23946. https://doi.org/10.1039/C8RA03911A
Liang X, Wu Q, Luan S, Yin Z, He C, Yin L, Zou Y, Yuan Z, Li L, Song X (2019) A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade. Eur J Med Chem 171: 129-168. https://doi.org/10.1016/j.ejmech.2019.03.034
Liang Y, Wu JL, Li X, Guo MQ, Leung LH, Zhou H, Liu L, Li N (2016b) Anti-cancer and Anti-inflammatory New Vakognavine-type Alkaloid from the Roots of Aconitum carmichaelii. Tetrahedron Letters 57: 5881-5884. https://doi.org/10.1016/j.tetlet.2016.11.065
Luan S, Gao Y, Liang X, Zhang L, Jing B (2021) Synthesis and structure-activity relationship of lipo-diterpenoid alkaloids with potential target of topoisomerase IIα for breast cancer treatment. Bioorganic Chemistry 109: 104699. https://doi.org/10.1016/j.bioorg.2021.104699
McClendon AK, Osheroff N (2007) DNA topoisomerase II, genotoxicity, and cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 623: 83-97. https://doi.org/10.1016/j.mrfmmm.2007.06.009
Mechetner E, Kyshtoobayeva A, Zonis S, Kim H, Stroup R, Garcia R, Parker RJ, Fruehauf JP (1998) Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clinical Cancer Research 4: 389-398.
Mingxin Tang, Sun G (1986) Aconitine's anti-tumor and anti-metastasis research and the observation of cancer treatment Beijing Journal of Traditional Chinese Medicine 27-28.
Mistry AR, Felix CA, Whitmarsh RJ, Annabel M, Andreas R, Bruno C, Anne P, Christoph W, Wiemels JL, Segal MR (2005) DNA topoisomerase II in therapy-related acute promyelocytic leukemia. New England Journal of Medicine 352: 1529-1538. https://doi.org/10.1056/NEJMoa042715
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791. https://doi.org/10.1002/jcc.21256
Nitiss JL (2009a) DNA topoisomerase II and its growing repertoire of biological functions. Nature Reviews Cancer 9: 327-337. https://doi.org/10.1038/nrc2608
Nitiss JL (2009b) Targeting DNA topoisomerase II in cancer chemotherapy. Nature Reviews Cancer 9: 338-350. https://doi.org/10.1038/nrc2607
Pierce LC, Salomon-Ferrer R, Augusto F. de Oliveira C, McCammon JA, Walker RC (2012) Routine access to millisecond time scale events with accelerated molecular dynamics. Journal of Chemical Theory and Computation 8: 2997-3002. https://doi.org/10.1021/ct300284c
Pommier Y (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6: 789-802. https://doi.org/10.1038/nrc1977
Qiuping Xu , Jinghan Liu, Liu B (2016) Progress in Study on Antitumor Activity of C19-, C20-Diterpenoid Alkaloids. Progress in Pharmaceutical Sciences 40: 3-10.
Salomon-Ferrer R, Götz AW, Poole D, Le Grand S, Walker RC (2013) Routine microsecond molecular dynamics simulations with Amber on GPUs. 2. Explicit solvent particle mesh Ewald. Journal of Chemical Theory and Computation 9: 3878-3888. https://doi.org/10.1021/ct400314y
Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17: 57-61.
Sauer LA, Dauchy RT, Blask DE (2000) Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Research 60: 5289-5295.
Schmitta F, Golda M, Rothemunda M, Andronacheb IC, Biersacka B, Rainer Schoberta, Mueller T (2019) New naphthopyran analogues of LY290181 as potential tumor vascular-disrupting agents. European Journal of Medicinal Chemistry 163: 160-168. https://doi.org/10.1016/j.ejmech.2018.11.055
Schoeffler AJ, Berger JM (2008) DNA topoisomerases: harnessing and constraining energy to govern chromosome topology. Quarterly Reviews of Biophysics 41: 41-101. https://doi.org/10.1017/S003358350800468X
Shatha AbuHammad, Zihlif M (2013) Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics 101: 213-220. https://doi.org/10.1016/j.ygeno.2012.11.009
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71: 209-249. https://doi.org/10.3322/caac.21660
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461. https://doi.org/10.1002/jcc.21334
Wada K (2012) Chapter 7 - Chemistry and Biological Activity of Diterpenoid Alkaloids. In: Atta ur R (ed.) Studies in Natural Products Chemistry. Elsevier, pp. 191-223. https://doi.org/10.1016/B978-0-444-59530-0.00007-1
Wada K, Chiba R, Kanazawa R, Matsuoka K, Suzuki M, Ikuta M, Goto M, Yamashita H, Lee K-H (2015a) Six new norditerpenoid alkaloids from Delphinium elatum. Phytochemistry Letters 12: 79-83. https://doi.org/10.1016/j.phytol.2015.02.010
Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2011) Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells. J Nat Med 65: 43-49. https://doi.org/10.1007/s11418-010-0452-3
Wada K, Ohkoshi E, Morrisnatschke SL, Bastow KF, Lee KH (2012) Cytotoxic esterified diterpenoid alkaloid derivatives with increased selectivity against a drug-resistant cancer cell line. Bioorganic & Medicinal Chemistry Letters 22: 249-252. https://doi.org/10.1016/j.bmcl.2011.11.026
Wada K, Ohkoshi E, Zhao Y, Goto M, Morrisnatschke SL, Lee KH (2015b) Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents. Bioorg Med Chem Lett 25: 1525-1531.
Wada K. YH ( 2019) Cytotoxic Effects of Diterpenoid Alkaloids Against Human Cancer Cells. Molecules 24: 2317. https://doi.org/10.3390/molecules24122317
Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. Journal of molecular graphics and modelling 25: 247-260. https://doi.org/10.1016/j.jmgm.2005.12.005
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25: 1157-1174.
Yamashita H, Miyao M, Hiramori K, Kobayashi D, Suzuki Y, Mizukami M, Goto M, Lee K-H, Wada K (2020) Cytotoxic diterpenoid alkaloid from Aconitum japonicum subsp. subcuneatum. Journal of Natural Medicines 74: 83-89. https://doi.org/10.1007/s11418-019-01346-z
Yamashita H, Takeda K, Haraguchi M, Abe Y, Kuwahara N, Suzuki S, Terui A, Masaka T, Munakata N, Uchida M, Nunokawa M, Kaneda K, Goto M, Lee K-H, Wada K (2018) Four new diterpenoid alkaloids from Aconitum japonicum subsp. subcuneatum. Journal of Natural Medicines 72: 230-237. https://doi.org/10.1007/s11418-017-1139-9
Yamashita H. MM, Hiramori K., Kobayashi D., Suzuki Y., Mizukami M. , Goto M. ,Lee K.‑H. , Wada K. (2020) Cytotoxic diterpenoid alkaloid from Aconitum japonicum subsp. subcuneatum. Journal of Natural Medicines 74: 83-89. https://doi.org/10.1007/s11418-019-01346-z